Rachael Jane Kimber

Title: Rachael Jane Kimber: Pioneer in Antibody Technologies

Introduction

Rachael Jane Kimber, based in Cambridge, GB, is an innovative inventor recognized for her significant contributions to the field of immunology. With her cutting-edge research and patent, she has made a profound impact on the development of therapeutic antibodies and related technologies.

Latest Patents

Rachael holds one notable patent titled "TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo." This patent encompasses antibodies that are specific for one or more antigens, as well as bispecific antibodies featuring domains directed towards targeted antigens. Additionally, it outlines immunocytokines and details methods of treatment, uses, and pharmaceutical compositions that incorporate these antibodies, bispecific antibodies, and immunocytokines.

Career Highlights

Currently, Rachael is employed at Kymab Limited, a company known for its advancements in therapeutic antibody development. Her dedication to her work and her groundbreaking research have established her as a key figure in her field.

Collaborations

Throughout her career, Rachael has collaborated with esteemed colleagues, including Joana De Abreu Carvalho and Jamie Iain Campbell. These collaborations have enhanced her research and widened the impact of her work in immunology.

Conclusion

Rachael Jane Kimber stands out as an influential inventor whose work on TIGIT antibodies is shaping the future of immunotherapy. Her contributions not only highlight her expertise but also underscore the importance of collaboration in driving innovation forward in the biomedical field.